Sentence examples for an inadequate control from inspiring English sources

These data support the contention that excessive levels of calmodulin may compromise the ability of the beta cell to metabolize glucose and to modulate the state of the K+ATP channel, resulting in an inadequate control of the membrane potential, which collectively impair [Ca2+]i and thus insulin secretion in response to glucose.

But the invisible hand of the market early proved to be an inadequate control mechanism.

Occurrence of DSS in only some patients at the late phase of infection is likely due to an inadequate control or an amplification of the primary inflammatory response aimed at fighting infection.

Our proposed explanatory model is powerful enough for reliably explaining factors related to an inadequate control of asthma.

This allowed a 98% power to detect a prevalence ratio of 1.39 for an inadequate control of asthma [ 15].

This adds further weight to the likelihood that lack of blinding and an inadequate control group accounted for the treatment benefit observed in Vertos II.

These arose from the subcategories: Good nursing implies providing appropriate health education; Acknowledging the Mourafiq (sitter) as a potential resource for the nursing, but also as a burden; Inadequate control and lack of influence; Cultural diversity and lack of dialog; and Views of women's weight gain in KSA society.

There is no clear consensus on the definition of "inadequate control", but a consensus statement (2009) of a working group drawn from the American Diabetes Association and the European Association for the Study of Diabetes suggested that "an HbA1c over 7% should serve as a call to action to initiate or change therapy"[6].

However, if their recall was not reliable, the use of this measure in adjusted analysis could lead to inadequate control of a potential confounder.

However, because current medication use may not reliably measure effects of past medication use, its use in adjusted analysis could again lead to inadequate control of a potential confounder.

We identified 28 randomised controlled trials comparing GLP-1 analogues with placebo, other glucose-lowering agents, or another GLP-1 analogue, in patients with type 2 diabetes with inadequate control on a single oral agent, or on dual therapy.